Skip to main navigation Skip to search Skip to main content

New Adenocarcinoma Research from Seoul National University College of Medicine Outlined (Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma)

Press/Media

Period26 Jun 2025

Media coverage

1

Media coverage

  • TitleNew Adenocarcinoma Research from Seoul National University College of Medicine Outlined (Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date26/06/25
    PersonsJungho Kim